Lenalidomide and Irritable bowel syndrome - a phase IV clinical study of FDA data

Summary:

Irritable bowel syndrome is reported as a side effect among people who take Lenalidomide (lenalidomide), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Eliquis, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Irritable bowel syndrome when taking Lenalidomide. It is created by eHealthMe based on reports of 52,873 people who have side effects when taking Lenalidomide from the FDA, and is updated regularly.

What is Lenalidomide?

Lenalidomide has active ingredients of lenalidomide. eHealthMe is studying from 52,881 Lenalidomide users. Check the latest studies of Lenalidomide.

What is Irritable bowel syndrome?

Irritable bowel syndrome is found to be associated with 1,316 drugs and 2,123 conditions by eHealthMe. Check the latest studies of Irritable bowel syndrome.



On Jul, 16, 2026

52,873 people reported to have side effects when taking Lenalidomide.
Among them, 16 people (0.03%) have Irritable bowel syndrome.

Could Lenalidomide cause Irritable bowel syndrome?

Among these 16 people:

How long have people been on Lenalidomide when they have Irritable bowel syndrome? *

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Irritable bowel syndrome when taking Lenalidomide? *

  • female: 25 %
  • male: 75 %

What is the age of people who have Irritable bowel syndrome when taking Lenalidomide? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 6.67 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 93.33 %

What are other drugs people take besides Lenalidomide? *

  1. Kyprolis: 5 people, 31.25%
  2. Acyclovir: 5 people, 31.25%
  3. Dexamethasone: 5 people, 31.25%
  4. Eliquis: 5 people, 31.25%
  5. Zometa: 2 people, 12.50%
  6. Darzalex: 2 people, 12.50%
  7. Accutane: 2 people, 12.50%
  8. Piperacillin And Tazobactam: 1 person, 6.25%
  9. Famotidine: 1 person, 6.25%
  10. Docetaxel: 1 person, 6.25%

What are other side effects people have besides Irritable bowel syndrome? *

  1. Diarrhea: 7 people, 43.75%
  2. Weight Decreased: 6 people, 37.50%
  3. Neuropathy Peripheral (surface nerve damage): 5 people, 31.25%
  4. Dyspnea (difficult or laboured breathing): 5 people, 31.25%
  5. Diastolic Dysfunction: 5 people, 31.25%
  6. Ventricular Arrhythmia (problem with the rate or rhythm of the heartbeat): 5 people, 31.25%
  7. Haemorrhagic Disorder (bleeding disorder): 5 people, 31.25%
  8. Coughing Up Blood: 5 people, 31.25%
  9. High Blood Pressure: 5 people, 31.25%
  10. Leukopenia (less number of white blood cells in blood): 5 people, 31.25%

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 14 people, 87.50%
  2. Atherosclerosis (disorder of the arteries): 5 people, 31.25%
  3. Pain: 2 people, 12.50%
  4. Constipation: 2 people, 12.50%
  5. Acne (skin problems that cause pimples): 2 people, 12.50%
  6. Thrombocytopenia (decrease of platelets in blood): 1 person, 6.25%
  7. Rashes (redness): 1 person, 6.25%
  8. Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 1 person, 6.25%
  9. Proteus Infection (proteus can cause urinary tract infections): 1 person, 6.25%
  10. Prostate Cancer: 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Lenalidomide and have Irritable bowel syndrome?

- Check whether Irritable bowel syndrome is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lenalidomide:

Irritable bowel syndrome treatments and more:

How severe was Irritable bowel syndrome and when was it recovered:

Expand to all the drugs that have ingredients of lenalidomide:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lenalidomide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Irritable bowel syndrome:

Browse all the conditions that are associated with Irritable bowel syndrome:


How the study uses the data?

The study uses data from the FDA. It is based on lenalidomide (the active ingredients of Lenalidomide) and Lenalidomide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: